Cory Berkland

PhD, University of Illinois, 2003
MS, University of Illinois, 2001
BS, Iowa State University, 1998
    View All People

    contact info:

    image of book cover

    The Berkland lab focuses on developing new therapeutics and biomaterials for improving human health

    Cory Berkland’s lab studies pharmaceuticals and biomaterials with a particular emphasis on molecular design, drug formulation, and transport in the human body. Professor Berkland is a co-founder of Orbis Biosciences (acquired by Adare Pharmaceuticals), Savara Pharmaceuticals (NASDAQ:SVRA), Bond Biosciences, and several other start-ups. Professor Berkland is currently CEO of Bond Biosciences and is an executive and chairman of the board for Kinimmune and Axioforce.